Gartner, Inc. Finite-lived Intangible Assets Acquired
Gartner, Inc. (IT) reported Finite-lived Intangible Assets Acquired of $990.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2025-02-13
- Gartner, Inc. finite-lived intangible assets acquired for the quarter ending 2023-12-31 was $0.00.
- Gartner, Inc. finite-lived intangible assets acquired for the quarter ending 2021-12-31 was $0.00.
- Gartner, Inc. finite-lived intangible assets acquired for the quarter ending 2021-09-30 was $40.00K.
- Gartner, Inc. finite-lived intangible assets acquired for the quarter ending 2017-12-31 was $10.20M, a 461.36% increase year-over-year.
- Gartner, Inc. finite-lived intangible assets acquired for fiscal 2023 was $990.00K.
- Gartner, Inc. finite-lived intangible assets acquired for fiscal 2021 was $19.50M.
- Gartner, Inc. finite-lived intangible assets acquired for fiscal 2019 was $5.25M.
- Gartner, Inc. finite-lived intangible assets acquired for fiscal 2017 was $1.60B, a 26898.31% increase from fiscal 2016.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 9 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $990.00K 10-K · filed 2025-02-13 | ||
| 2023-09-30 | $990.00K 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $40.00K derived: sum of 2 quarters · filed 2023-02-16 | $19.50M 10-K · filed 2023-02-16 | |
| 2021-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $19.50M 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | $19.46M 10-Q · filed 2021-08-03 | |||
| 2019-12-31 | $5.25M 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $10.30M derived: sum of 2 quarters · filed 2019-02-22 | $1.59B derived: sum of 3 quarters · filed 2019-02-22 | $1.60B 10-K · filed 2019-02-22 |
| 2017-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.58B derived: sum of 2 quarters · filed 2017-11-02 | $1.59B 10-Q · filed 2017-11-02 | $1.59B derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-06-30 | $1.58B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.59B 10-Q · filed 2017-08-08 | $1.59B derived: sum of 3 quarters · filed 2018-02-22 | $1.58B derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-03-31 | $10.50M 10-Q · filed 2017-05-04 | $12.32M derived: sum of 2 quarters · filed 2018-02-22 | $1.63M derived: sum of 3 quarters · filed 2018-02-22 | |
| 2016-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$8.87M derived: sum of 2 quarters · filed 2018-02-22 | $5.93M 10-K · filed 2018-02-22 | |
| 2016-09-30 | -$10.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.11M 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | $14.80M 10-Q · filed 2016-08-04 | |||
| 2015-12-31 | $7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $79.61M 10-K · filed 2017-02-22 | ||
| 2015-09-30 | $71.95M 10-Q · filed 2015-11-05 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$26.00K derived: sum of 2 quarters · filed 2016-02-24 | $2.29M derived: sum of 3 quarters · filed 2016-02-24 | $31.98M 10-K · filed 2016-02-24 |
| 2014-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $2.29M derived: sum of 2 quarters · filed 2014-11-06 | $31.98M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $32.00M 10-Q · filed 2014-08-05 | ||
| 2014-03-31 | $29.69M 10-Q · filed 2014-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |